Osmotic capsules: A universal oral, controlled-release drug delivery dosage form

被引:29
作者
Waterman, Kenneth C. [1 ]
Goeken, G. Scott [1 ]
Konagurthu, Sanjay [2 ]
Likar, Michael D. [1 ]
MacDonald, Bruce C. [1 ]
Mahajan, Nidhi [1 ]
Swaminathan, Vidya [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
[2] Bend Res Inc, Bend, OR 97701 USA
关键词
Osmotic drug delivery; Oral controlled release; ASYMMETRIC MEMBRANE CAPSULES; POLYMERS;
D O I
10.1016/j.jconrel.2011.02.001
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An osmotic, oral, controlled-release capsule is described. This capsule provides drug delivery at fixed delivery rates (T-80% = 6 or 14 h) independent of drug properties (e.g., solubility) or drug loading, thereby allowing rapid development of investigational or commercial drugs, especially for proof-of-concept type clinical studies. The capsule body and cap are prepared with cellulose acetate and polyethylene glycol in acetone and water using high density polyethylene molds as templates and a conventional tablet pan coater. After the shells are removed from the molds manually, a laser hole is drilled in the end of the capsule body. The drug is introduced as a shaped tablet admixed with polyethylene oxide. A "push" tablet consisting of high molecular weight polyethylene oxide, microcrystalline cellulose, and sodium chloride is also inserted into the capsule body. The capsule halves lock together due to ridges, alleviating the need for a banding operation. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 27 条
  • [1] Propranolol hydrochloride osmotic capsule with controlled onset of release
    Barzegar-Jalali, Mohammad
    Adibkia, Khosro
    Mohammadi, Ghobad
    Zeraati, Mahdi
    Bolagh, Behnaz Aghaee Ghare
    Nokhodchi, Ali
    [J]. DRUG DELIVERY, 2007, 14 (07) : 461 - 468
  • [2] Cardinal Jr, 2000, DRUGS PHARM SCI, V102, P411
  • [3] Osmotic delivery of flurbiprofen through controlled porosity asymmetric membrane capsule
    Choudhury, Pratim K.
    Chauhan, Chetan S.
    Ranawat, Mahendra S.
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (10) : 1135 - 1141
  • [4] Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form
    Conley, Robert
    Gupta, Suneel K.
    Sathyan, Gayatri
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (10) : 1879 - 1892
  • [5] CRAIG DQM, 2004, B TECH GATTEFOSSE, V97, P9
  • [6] GAURAV K, 2006, PHARMACOL REV, V4, P121
  • [7] Solubility of paracetamol in pure solvents
    Granberg, RA
    Rasmuson, ÅC
    [J]. JOURNAL OF CHEMICAL AND ENGINEERING DATA, 1999, 44 (06) : 1391 - 1395
  • [8] GUPTA V, 2005, DRUG DEL TECHNOL, V5, P68
  • [9] ASYMMETRIC-MEMBRANE TABLET COATINGS FOR OSMOTIC DRUG-DELIVERY
    HERBIG, SM
    CARDINAL, JR
    KORSMEYER, RW
    SMITH, KL
    [J]. JOURNAL OF CONTROLLED RELEASE, 1995, 35 (2-3) : 127 - 136
  • [10] Surfactant effects upon dissolution patterns of carbamazepine immediate release tablet
    Lee, H
    Park, SA
    Sah, H
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (01) : 120 - 126